KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Amgen (AMGN) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $5.2 billion.

  • Amgen's Accumulated Depreciation & Amortization fell 760.01% to $5.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.2 billion, marking a year-over-year decrease of 760.01%. This contributed to the annual value of $5.2 billion for FY2025, which is 760.01% down from last year.
  • Amgen's Accumulated Depreciation & Amortization amounted to $5.2 billion in Q4 2025, which was down 760.01% from $5.6 billion recorded in Q4 2024.
  • Amgen's 5-year Accumulated Depreciation & Amortization high stood at $5.6 billion for Q4 2024, and its period low was $841.0 million during Q1 2021.
  • Its 5-year average for Accumulated Depreciation & Amortization is $3.7 billion, with a median of $3.7 billion in 2022.
  • Per our database at Business Quant, Amgen's Accumulated Depreciation & Amortization soared by 3736.18% in 2024 and then crashed by 760.01% in 2025.
  • Over the past 5 years, Amgen's Accumulated Depreciation & Amortization (Quarter) stood at $3.4 billion in 2021, then rose by 0.56% to $3.4 billion in 2022, then increased by 19.14% to $4.1 billion in 2023, then soared by 37.36% to $5.6 billion in 2024, then dropped by 7.6% to $5.2 billion in 2025.
  • Its Accumulated Depreciation & Amortization stands at $5.2 billion for Q4 2025, versus $5.6 billion for Q4 2024 and $4.1 billion for Q4 2023.